Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Atypical parkinsonian syndromes: a general neurologist's perspective.

Deutschländer AB, Ross OA, Dickson DW, Wszolek ZK.

Eur J Neurol. 2018 Jan;25(1):41-58. doi: 10.1111/ene.13412. Epub 2017 Sep 28. Review.

PMID:
28803444
2.

Clinicopathological correlations in behavioural variant frontotemporal dementia.

Perry DC, Brown JA, Possin KL, Datta S, Trujillo A, Radke A, Karydas A, Kornak J, Sias AC, Rabinovici GD, Gorno-Tempini ML, Boxer AL, De May M, Rankin KP, Sturm VE, Lee SE, Matthews BR, Kao AW, Vossel KA, Tartaglia MC, Miller ZA, Seo SW, Sidhu M, Gaus SE, Nana AL, Vargas JNS, Hwang JL, Ossenkoppele R, Brown AB, Huang EJ, Coppola G, Rosen HJ, Geschwind D, Trojanowski JQ, Grinberg LT, Kramer JH, Miller BL, Seeley WW.

Brain. 2017 Dec 1;140(12):3329-3345. doi: 10.1093/brain/awx254.

3.

Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.

Seltman RE, Matthews BR.

CNS Drugs. 2012 Oct 1;26(10):841-70. doi: 10.2165/11640070-000000000-00000. Review.

PMID:
22950490
4.

Frontotemporal lobar degeneration: a clinical approach.

Karageorgiou E, Miller BL.

Semin Neurol. 2014 Apr;34(2):189-201. doi: 10.1055/s-0034-1381735. Epub 2014 Jun 25. Review.

PMID:
24963678
5.

Structural magnetic resonance imaging in frontotemporal lobar dementia.

Bertrand A, Stroër S, Le Ber I, Teichmann M, Dormont D.

Geriatr Psychol Neuropsychiatr Vieil. 2017 Sep 1;15(3):285-294. doi: 10.1684/pnv.2017.0686.

PMID:
28872040
6.

Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.

Gatto EM, Allegri RF, Da Prat G, Chrem Mendez P, Hanna DS, Dorschner MO, Surace EI, Zabetian CP, Mata IF.

Neurobiol Aging. 2017 May;53:195.e11-195.e17. doi: 10.1016/j.neurobiolaging.2017.02.002. Epub 2017 Feb 10.

7.

Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.

Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell JL, Duffy JR, Parisi JE, Dickson DW.

Neurology. 2006 Jan 10;66(1):41-8.

PMID:
16401843
8.

Clinic, neuropathology and molecular genetics of frontotemporal dementia: a mini-review.

Pan XD, Chen XC.

Transl Neurodegener. 2013 Apr 19;2(1):8. doi: 10.1186/2047-9158-2-8.

9.

Early vs late age at onset frontotemporal dementia and frontotemporal lobar degeneration.

Seo SW, Thibodeau MP, Perry DC, Hua A, Sidhu M, Sible I, Vargas JNS, Gaus SE, Rabinovici GD, Rankin KD, Boxer AL, Kramer JH, Rosen HJ, Gorno-Tempini ML, Grinberg LT, Huang EJ, DeArmond SJ, Trojanowski JQ, Miller BL, Seeley WW.

Neurology. 2018 Mar 20;90(12):e1047-e1056. doi: 10.1212/WNL.0000000000005163. Epub 2018 Feb 16.

10.

Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.

Sajjadi SA, Acosta-Cabronero J, Patterson K, Diaz-de-Grenu LZ, Williams GB, Nestor PJ.

Brain. 2013 Jul;136(Pt 7):2253-61. doi: 10.1093/brain/awt118. Epub 2013 May 31.

PMID:
23729473
11.

The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships.

Snowden JS, Thompson JC, Stopford CL, Richardson AM, Gerhard A, Neary D, Mann DM.

Brain. 2011 Sep;134(Pt 9):2478-92. doi: 10.1093/brain/awr189. Epub 2011 Aug 11.

PMID:
21840888
12.

Frontotemporal Dementia.

Olney NT, Spina S, Miller BL.

Neurol Clin. 2017 May;35(2):339-374. doi: 10.1016/j.ncl.2017.01.008. Review.

13.

A disease-specific metabolic brain network associated with corticobasal degeneration.

Niethammer M, Tang CC, Feigin A, Allen PJ, Heinen L, Hellwig S, Amtage F, Hanspal E, Vonsattel JP, Poston KL, Meyer PT, Leenders KL, Eidelberg D.

Brain. 2014 Nov;137(Pt 11):3036-46. doi: 10.1093/brain/awu256. Epub 2014 Sep 9.

14.

Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.

Rohrer JD, Lashley T, Schott JM, Warren JE, Mead S, Isaacs AM, Beck J, Hardy J, de Silva R, Warrington E, Troakes C, Al-Sarraj S, King A, Borroni B, Clarkson MJ, Ourselin S, Holton JL, Fox NC, Revesz T, Rossor MN, Warren JD.

Brain. 2011 Sep;134(Pt 9):2565-81. doi: 10.1093/brain/awr198.

15.

Prediction of pathology in primary progressive language and speech disorders.

Deramecourt V, Lebert F, Debachy B, Mackowiak-Cordoliani MA, Bombois S, Kerdraon O, Buée L, Maurage CA, Pasquier F.

Neurology. 2010 Jan 5;74(1):42-9. doi: 10.1212/WNL.0b013e3181c7198e. Epub 2009 Nov 25.

PMID:
19940270
16.

Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update.

Oeckl P, Steinacker P, Feneberg E, Otto M.

J Neurochem. 2016 Aug;138 Suppl 1:184-92. doi: 10.1111/jnc.13669. Epub 2016 Jun 15. Review.

17.

MRI signatures of the frontotemporal lobar degeneration continuum.

Agosta F, Galantucci S, Magnani G, Marcone A, Martinelli D, Antonietta Volontè M, Riva N, Iannaccone S, Ferraro PM, Caso F, Chiò A, Comi G, Falini A, Filippi M.

Hum Brain Mapp. 2015 Jul;36(7):2602-14. doi: 10.1002/hbm.22794. Epub 2015 Mar 28.

18.

Apathy and impulsivity in frontotemporal lobar degeneration syndromes.

Lansdall CJ, Coyle-Gilchrist ITS, Jones PS, Vázquez Rodríguez P, Wilcox A, Wehmann E, Dick KM, Robbins TW, Rowe JB.

Brain. 2017 Jun 1;140(6):1792-1807. doi: 10.1093/brain/awx101.

19.

A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.

Magdalinou NK, Paterson RW, Schott JM, Fox NC, Mummery C, Blennow K, Bhatia K, Morris HR, Giunti P, Warner TT, de Silva R, Lees AJ, Zetterberg H.

J Neurol Neurosurg Psychiatry. 2015 Nov;86(11):1240-7. doi: 10.1136/jnnp-2014-309562. Epub 2015 Jan 14.

20.

Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.

Rabinovici GD, Miller BL.

CNS Drugs. 2010 May;24(5):375-98. doi: 10.2165/11533100-000000000-00000. Review.

Supplemental Content

Support Center